Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Man dies after first human case of H5N2 avian flu
The virus has been detected in poultry in Mexico.
The cause of the case in Mexico is not currently known.

A 59-year-old man in Mexico has died after becoming the first known human to contract the H5N2 strain of avian influenza.

The individual, who had multiple underlying health conditions, was hospitalised in Mexico City on 24 April after developing symptoms including fever, shortness of breath, diarrhoea, and nausea. He passed away the same day.

A respiratory sample, sent away for testing, was found to be positive for the H5N2 strain. The World Health Organization (WHO) was notified.

Although the H5N2 strain has been detected in poultry in Mexico, the source of the individual’s exposure is not currently known.

Contacts of the patient were identified and monitored, but none of them tested positive for the virus. WHO has assessed the current risk to the general human population as low.

The case comes at a time when a different strain of avian influenza, H5N1, has caused two human cases in the USA linked to an ongoing outbreak among dairy cattle. Both patients experienced mild eye symptoms.

Ian Jones, professor of virology at the University of Reading, said: “It is impossible to generalise from a single case. However, as H5N2 is present in Mexico and the infected individual had underlying medical conditions, which may have contributed to the outcome, it would be reasonable to suppose this is a one-off case of zoonotic transfer with no potential to spread.

“This would be consistent with previous examples of occasional avian influenza infections in people. Unless or until there is evidence of strain adaptation or sustained transmission, the risk to the population is very low.

“The case should act to reinforce the importance of monitoring and eradicating outbreaks in poultry as soon as they occur.”

Image © Shutterstock

Become a member or log in to add this story to your CPD history

NOAH board elected

News Story 1
 NOAH has elected its board team, as part of its annual general meeting.

Ned Flaxman, general manager at Norbrook Laboratories Ltd, retains his position as chair, which he has held since June 2023.

Caitrina Oakes (Vetoquinol) remains past chair, and Matthew Frost (Elanco) remains treasurer.

Andrew Buglass (Eco Animal Health Ltd), Oya Canbas (Zoetis) and Charlotte Covell (Virbac) are newly elected vice-chairs. Meanwhile Roy Geary (Ceva) and John Toole (Beaphar) join the NOAH Board of Management.

Dawn Howard, NOAH chief executive, said: "I congratulate all the officers and board members who have been elected or re-elected today.

"I look forward to working together to ensure that NOAH continues to deliver at the highest standard for its members." 

Click here for more...
News Shorts
Series two of SCOPS podcast launched

The Sustainable Control of Parasites in Sheep (SCOPS) Group has launched the second series of its podcast.

The series will comprise four episodes, with topics including the sustainable use of parasite treatments, effective quarantining, administrating a mid/late season dose, and tackling resistance to multiple groups of anthelmintic.

Kevin Harrison, Gloucestershire sheep farmer and SCOPS chair, said: "The podcast is suitable for sheep farmers, vets and advisers, so please subscribe and spread the word if you enjoy the content.

"All episodes from series one are still available online, as well as the new episodes being added."

The podcast is available on the SCOPS website and other podcast platforms.